Article
Establishing PAX6 as a biomarker to detect early loss of ocular phenotype in human patients with Sjögren's syndrome.
Investigative ophthalmology & visual science - 16 Sept 2014
McNamara Nancy A, Gallup Marianne, Porco Travis C
Abstract excerpt
PURPOSE: Sjögren's syndrome (SS) is a common autoimmune disease that can cause aqueous-deficient dry eye and the aberrant differentiation of ocular mucosal epithelial cells toward a lineage that is pathologically keratinized and skin-like. PAX6 is the master regulator of corneal lineage commitment. Recently, we showed a functional role for PAX6 in preventing ocular surface damage induced by the proinflammatory...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
